相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。PRECISE-DAPT score for bleeding risk prediction in patients on dual or single antiplatelet regimens: insights from the GLOBAL LEADERS and GLASSY
Felice Gragnano et al.
EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY (2022)
Comparative external validation of the PRECISE-DAPT and PARIS risk scores in 4424 acute coronary syndrome patients treated with prasugrel or ticagrelor
Matteo Bianco et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2020)
Clinical Usefulness of PRECISE-DAPT Score for Predicting Bleeding Events in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention An Analysis From the SMART-DATE Randomized Trial
Ki Hong Choi et al.
CIRCULATION-CARDIOVASCULAR INTERVENTIONS (2020)
Ticagrelor With or Without Aspirin After Complex Percutaneous Coronary Intervention
George Dangas et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)
Validation of the Academic Research Consortium High Bleeding Risk Definition in Contemporary PCI Patients
Davide Cao et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)
Comparative Assessment of Predictive Performance of PRECISE-DAPT, CRUSADE, and ACUITY Scores in Risk Stratifying 30-Day Bleeding Events
Hideyuki Kawashima et al.
THROMBOSIS AND HAEMOSTASIS (2020)
Validation of the Academic Research Consortium for High Bleeding Risk (ARC-HBR) criteria in patients undergoing percutaneous coronary intervention and comparison with contemporary bleeding risk scores
Yasushi Ueki et al.
EUROINTERVENTION (2020)
Effect of P2Y12 Inhibitor Monotherapy vs Dual Antiplatelet Therapy on Cardiovascular Events in Patients Undergoing Percutaneous Coronary Intervention The SMART-CHOICE Randomized Clinical Trial
Joo-Yong Hahn et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)
Effect of 1-Month Dual Antiplatelet Therapy Followed by Clopidogrel vs 12-Month Dual Antiplatelet Therapy on Cardiovascular and Bleeding Events in Patients Receiving PCI The STOPDAPT-2 Randomized Clinical Trial
Hirotoshi Watanabe et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)
Bleeding Risk Scores and Scales of Frailty for the Prediction of Haemorrhagic Events in Older Adults with Acute Coronary Syndrome: Insights from the FRASER study
Rita Pavasini et al.
CARDIOVASCULAR DRUGS AND THERAPY (2019)
PROBAST: A Tool to Assess Risk of Bias and Applicability of Prediction Model Studies: Explanation and Elaboration
Karel G. M. Moons et al.
ANNALS OF INTERNAL MEDICINE (2019)
2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS
Marco Valgimigli et al.
EUROPEAN HEART JOURNAL (2018)
Validation of contemporary risk scores in predicting coronary thrombotic events and major bleeding in patients with acute coronary syndrome after drug-eluting stent implantations
Li Song et al.
CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS (2018)
Development and external validation of a post-discharge bleeding risk score in patients with acute coronary syndrome: The BleeMACS score
Sergio Raposeiras-Roubin et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2018)
6-month versus 12-month or longer dual antiplatelet therapy after percutaneous coronary intervention in patients with acute coronary syndrome (SMART-DATE): a randomised, open-label, non-inferiority trial
Joo-Yong Hahn et al.
LANCET (2018)
Evolution of Coronary Stent Technology and Implications for Duration of Dual Antiplatelet Therapy
Jae Youn Moon et al.
PROGRESS IN CARDIOVASCULAR DISEASES (2018)
Prediction of Post-Discharge Bleeding in Elderly Patients with Acute Coronary Syndromes: Insights from the BleeMACS Registry
Alberto Garay et al.
THROMBOSIS AND HAEMOSTASIS (2018)
Optimal duration of dual antiplatelet therapy for coronary artery disease
W. J. Kikkert et al.
NETHERLANDS HEART JOURNAL (2018)
Assessing the performance of the PRECISE-DAPT and PARIS risk scores for predicting one-year out-of-hospital bleeding in acute coronary syndrome patients
Emad Abu-Assi et al.
EUROINTERVENTION (2018)
External Validation of the DAPT Score in a Nationwide Population
Peter Ueda et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)
Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial
Pascal Vranckx et al.
LANCET (2018)
Performance of PRECISE-DAPT Score for Predicting Bleeding Complication During Dual Antiplatelet Therapy
Sun Young Choi et al.
CIRCULATION-CARDIOVASCULAR INTERVENTIONS (2018)
ACC/AHA Versus ESC Guidelines on Dual Antiplatelet Therapy JACC Guideline Comparison
Davide Capodanno et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)
Predicting Long-Term Bleeding After Percutaneous Coronary Intervention
Praneet K. Sharma et al.
CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS (2017)
Derivation and validation of the predicting bleeding complications in patients undergoing stent implantation and subsequent dual antiplatelet therapy (PRECISE-DAPT) score: a pooled analysis of individual-patient datasets from clinical trials
Francesco Costa et al.
LANCET (2017)
Development and Validation of a Prediction Rule for Benefit and Harm of Dual Antiplatelet Therapy Beyond 1 Year After Percutaneous Coronary Intervention
Robert W. Yeh et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)
Coronary Thrombosis and Major Bleeding After PCI With Drug-Eluting Stents Risk Scores From PARIS
Usman Baber et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2016)
2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease
Glenn N. Levine et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2016)
Incremental Value of the CRUSADE, ACUITY, and HAS-BLED Risk Scores for the Prediction of Hemorrhagic Events After Coronary Stent Implantation in Patients Undergoing Long or Short Duration of Dual Antiplatelet Therapy
Francesco Costa et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2015)
Stent Thrombosis A Clinical Perspective
Bimmer E. Claessen et al.
JACC-CARDIOVASCULAR INTERVENTIONS (2014)
Three vs Twelve Months of Dual Antiplatelet Therapy After Zotarolimus-Eluting Stents The OPTIMIZE Randomized Trial
Fausto Feres et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)
CRUSADE bleeding risk score validation for ST-segment-elevation myocardial infarction undergoing primary percutaneous coronary intervention
Albert Ariza-Sole et al.
THROMBOSIS RESEARCH (2013)
Comparison of the performance of the CRUSADE, ACUITY-HORIZONS, and ACTION bleeding risk scores in STEMI undergoing primary PCI: insights from a cohort of 1391 patients
X. Flores-Rios et al.
EUROPEAN HEART JOURNAL-ACUTE CARDIOVASCULAR CARE (2013)
A New Strategy for Discontinuation of Dual Antiplatelet Therapy The RESET Trial (REal Safety and Efficacy of 3-month dual antiplatelet Therapy following Endeavor zotarolimus-eluting stent implantation)
Byeong-Keuk Kim et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2012)
Stent thrombosis with drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis
Tullio Palmerini et al.
LANCET (2012)
In-Hospital Major Bleeding During ST-Elevation and Non ST-Elevation Myocardial Infarction Care: Derivation and Validation of a Model from the ACTION Registry®-GWTG™
Robin Mathews et al.
AMERICAN JOURNAL OF CARDIOLOGY (2011)
A Risk Score to Predict Bleeding in Patients With Acute Coronary Syndromes
Roxana Mehran et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)
Baseline Risk of Major Bleeding in Non-ST-Segment-Elevation Myocardial Infarction The CRUSADE (Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA guidelines) Bleeding Score
Sumeet Subherwal et al.
CIRCULATION (2009)
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration
Alessandro Liberati et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2009)
分享论文
